Biotech and Pharmaceuticals Medicine

  • Jan 9- The U.S. Food and Drug Administration said on Monday it has approved Egalet Corp's long-acting opioid painkiller, Arymo ER. The decision follows the recommendation of an independent panel of advisors to the FDA, which in August voted 18-1 in favor of approval. The FDA did not immediately say whether it has granted the abuse-deterrent label.

  • Jan 9- The U.S. Food and Drug Administration said on Monday it has approved Egalet Corp's long-acting opioid painkiller, Arymo ER. FDA in August voted 18-1 in favor of approval and recommended the drug be labeled as an abuse-deterrent product by the intravenous, nasal and oral routes of abuse. http://bit.ly/2jv97Ld. Lawmakers across the United States are...

  • CVS

    Every state is reporting influenza outbreaks, with the Northeast and Northwest among the hardest areas hit, according to the Centers for Disease Control and Prevention.

  • SANTIAGO, Jan 6- Chile's Agriculture and Livestock Service said on Friday that the strain of bird flu detected at a turkey production plant in the country's central Valparaiso region is not highly dangerous. It added that the results would allow for normal exports from Chile to continue, after countries such as Peru halted poultry imports from the neighboring...

  • A man wearing a 3M mask in Beijing

    The patient said he hadn't had any recent exposure to poultry or wet markets, according to the Centre for Health Protection.

  • CHICAGO, Jan 5- Scientists have shown conclusively that treatment not only improves the health of people infected with HIV, it also stops transmission of the virus that causes AIDS. But the roadmap is tentative, and complicated: it would keep the Medicaid expansion and the new individual insurance plans in place and delay major changes for up to three years.

  • Halozyme's shares rose as much as 16.3 percent to $12.43. Sunil Hingorani, the study's principal investigator. In Halozyme's trials so far, about 35 to 40 percent of pancreatic cancer patients have elevated HA levels, Chief Executive Helen Torley told Reuters.

  • Halozyme's shares shot up 21.6 percent to $13 before the opening bell on Thursday. Sunil Hingorani, the study's principal investigator. Pancreatic cancer is the third-leading cause of cancer-related death in the United States, killing about 41,780 Americans in 2016, the American Cancer Society estimates.

  • Jan 5- Synthetic Biologics Inc said its experimental treatment designed to reduce antibiotic-resistant "superbug" infections- notably life-threatening C. difficile- outperformed a placebo in a trial. The company's oral enzyme, ribaxamase, met the main goal of significantly reducing Clostridium difficile infection, the most common cause of...

  • Jan 5- Halozyme Therapeutics Inc said its flagship drug delivery technology in tandem with therapies from Celgene Corp and Eli Lilly and Co succeeded in a mid-stage study involving patients with an advanced form of pancreatic cancer. Shares of Halozyme were up 47.3 percent at $15.77 in trading before the opening bell on Thursday. Pancreatic cancer is the...

  • Jan 5- Halozyme Therapeutics Inc said its lead drug to treat a late form of pancreated cancer met the main goal in a mid-stage study, sending its shares soaring in premarket trading. Pancreatic cancer is the third-leading cause of cancer-related death in the United States. Halozyme's shares were up 44 percent at $15.40 in trading before the opening bell on...

  • Jan 5- Synthetic Biologics Inc said on Thursday its experimental product designed to reduce antibiotic-resistant infections outperformed a placebo in a mid-stage trial. The company's oral enzyme ribaxamase met the main goal of significantly reducing Clostridium difficile infection versus a placebo in the 412- patient study. The company's shares were...

  • SANTIAGO, Jan 4- Chile has detected bird flu at a turkey production plant run by poultry producer Agrosuper in the country's central Valparaiso region, the Agriculture and Livestock Service said on Wednesday. In 2002, a highly infectious strain of bird flu was detected in Chile for the first time, curtailing poultry exports. Different strains of bird flu, which...

  • FDA CONDITIONALLY APPROVES FIRST NEW ANIMAL DRUG. FOR TREATING LYMPHOMA IN DOGS@ lymphoma in dogs@. FDA conditionally approves tanovea-ca1, first new animal drug for treating lymphoma in dogs.

  • Jan 3- Inotek Pharmaceuticals Corp's shares plunged 71 percent to a record low on Tuesday after the company said its lead experimental drug failed a late-stage study, citing a stronger-than-expected placebo effect. There is no cure for glaucoma, the second-leading cause of blindness in the world, according to the World Health Organization.

  • Jan 3- Inotek Pharmaceuticals Corp said its experimental glaucoma treatment failed a late-stage study, citing a stronger-than-expected placebo effect. The company's stock slumped 64.8 percent to $2.15 in premarket trading on Tuesday and was set for its worst day ever. Aerie submitted a marketing application in September but that was withdrawn in October...

  • Elderly retiree medicare

    Most retirees depend on Medicare, but it's not a one-stop program, and it requires a lot of research. Here's what you need to know.

  • Jan 3- Inotek Pharmaceuticals Corp said its experimental glaucoma treatment failed a late-stage study, citing a stronger-than-expected placebo effect. The company's shares slumped 65.57 percent to $2.10 in premarket trading on Tuesday. Inotek's lead drug, trabodenoson, was no better than a placebo in reducing fluid pressure in the eye in patients with the...

  • Medicare enrollment

    With Medicare benefits at risk under the Trump administration, here’s what you need to know about why this could impact more than just the Americans under the Medicare umbrella.

  • Olav Hellebo, CEO at ReNeuron, discusses the value of stem cell treatment as well as investment in his research area.